26 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
PFE Pfizer, Inc. $43.01 $252.13B N/A
Article Searches
This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy https://www.fool.com/investing/2019/05/28/this-just-in-goldman-sachs-picks-4-big-pharma-stoc.aspx?source=iedfolrf0000001 May 28, 2019 - And the analyst really likes one in particular.
Dow 30 Stock Roundup: BA's Dreamliner Order, MSFT LinkedIn's Drawbridge Buyout Plan http://www.zacks.com/stock/news/422744/dow-30-stock-roundup-bas-dreamliner-order-msft-linkedins-drawbridge-buyout-plan?cid=CS-ZC-FT-422744 May 31, 2019 - The index endured another tough week as investors braced for an economic slowdown.
Merck's Keytruda Improves 5-Year Survival in Lung Cancer http://www.zacks.com/stock/news/423872/mercks-keytruda-improves-5-year-survival-in-lung-cancer?cid=CS-ZC-FT-423872 Jun 03, 2019 - Merck (MRK) presents longest follow-up data for Keytruda in advance lung cancer at ASCO 2019. The five-year overall survival rates in the Keytruda arm are better than historical rates
Blueprint Medicines' NDA for Avapritinib on Track for GIST http://www.zacks.com/stock/news/423983/blueprint-medicines-nda-for-avapritinib-on-track-for-gist?cid=CS-ZC-FT-423983 Jun 03, 2019 - Blueprint Medicines (BPMC) reports data on avapritinib from NAVIGATOR study for treating patients with PDGFRA Exon 18 mutant GIST and the fourth-line GIST.
Top Research Reports for Pfizer, Coca-Cola & VMware http://www.zacks.com/research-daily/424605/top-research-reports-for-pfizer-coca-cola-vmware?cid=CS-ZC-FT-424605 Jun 04, 2019 - Top Research Reports for Pfizer, Coca-Cola & VMware
Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft http://www.zacks.com/stock/news/425457/zacks-market-edge-highlights-pfizer-vanguard-sp-500-etf-global-x-social-media-etf-kraneshares-china-internet-etf-and-microsoft?cid=CS-ZC-FT-425457 Jun 06, 2019 - Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft
Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer http://www.zacks.com/stock/news/428338/mercks-keytruda-wins-fda-nod-for-first-line-head-neck-cancer?cid=CS-ZC-FT-428338 Jun 12, 2019 - Merck's (MRK) Keytruda is already approved for use in 15 cancer indications across 10 different tumor types in the United States.
Top Ranked Income Stocks to Buy for June 12th http://www.zacks.com/commentary/428514/top-ranked-income-stocks-to-buy-for-june-12th?cid=CS-ZC-FT-428514 Jun 12, 2019 - Top Ranked Income Stocks to Buy for June 12th
Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti http://www.zacks.com/stock/news/429548/amgen-allergan-get-fda-nod-for-herceptin-biosimilar-kanjinti?cid=CS-ZC-FT-429548 Jun 14, 2019 - FDA approves Amgen (AMGN) and Allergan's Kanjiniti, a biosimilar version of Roche's (RHHBY) breast cancer drug, Herceptin.
Company News For Jun 18, 2019 http://www.zacks.com/stock/news/431072/company-news-for-jun-18-2019?cid=CS-ZC--431072 Jun 18, 2019 - Companies In The News Are: DISH,TMUS,S,ARRY,PFE,BID,BA

Pages: 123

Page 1>